Log In
BCIQ
Print this Print this
 

Hu5F9-G4

  Manage Alerts
Collapse Summary General Information
Company Forty Seven Inc.
DescriptionHumanized mAb against CD47
Molecular Target CD47
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/24/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today